FMR CORP 13D/13G Filings for Dyne Therapeutics, Inc. (DYN)

FMR CORP 13D and 13G filings for Dyne Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2025-02-12
09:28 am
Sale		 2024-12-31 13G Dyne Therapeutics, Inc.
DYN		 FMR CORP 7,996,931
7.900%		 -1,029,766decrease
(-11.41%)		 Filing
2024-11-12
09:55 am
Purchase		 2024-11-08 13G Dyne Therapeutics, Inc.
DYN		 FMR CORP 9,026,697
8.990%		 9,026,697increase
(New Position)		 Filing